Literature DB >> 15615813

Subunit-specific contribution to agonist binding and channel gating revealed by inherited mutation in muscle acetylcholine receptor M3-M4 linker.

Xin-Ming Shen1, Kinji Ohno, Steven M Sine, Andrew G Engel.   

Abstract

We trace the cause of congenital myasthenic syndromes in two patients to mutations in the epsilon subunit of the muscle acetylcholine receptor (AChR). Both patients harbour deletion of an asparagine residue in the epsilon subunit (epsilonN436del) at the C-terminus of the cytoplasmic loop linking the third (M3) and fourth (M4) transmembrane domains. The presence of a null mutation in the second allele of the epsilon subunit shows that epsilonN346del determines the phenotype. Endplate studies show markedly reduced expression of the epsilonN346del-AChR and compensatory accumulation of fetal gamma-AChR. Expression studies in HEK cells reveal decreased expression of epsilonN436del-AChR and abnormally brief channel openings. Thus, neuromuscular transmission is compromised by AChR deficiency, fast channel kinetics of the epsilonN346del-AChR and incomplete phenotypic rescue by gamma-AChR. Single-channel kinetic analysis shows that the epsilonN436del shortens channel openings by reducing stability of the diliganded receptor: rates of channel closing and of ACh dissociation are increased and the rate of channel opening is decreased. In addition to shortening the M3-M4 loop, epsilonN436del shifts a negatively charged aspartic acid residue adjacent to M4; the effects of epsilonN436del are shown to result from shortening of the M3-M4 loop and not from juxtaposition of a negative charge to M4. To determine whether the consequences of epsilonN346del are subunit-specific, we deleted residues that align with epsilonN436 in beta, delta and alpha subunits. Each deletion mutant reduces AChR expression, but whereas the beta and delta mutants curtail channel open duration, the alpha mutant strikingly prolongs open duration. Kinetic analysis reveals that the alpha mutant increases the stability of the diliganded receptor: rates of channel closing and of ACh dissociation are decreased and the rate of channel opening is increased. The overall studies reveal subunit asymmetry in the contributions of the M3-M4 loops in optimizing AChR activation through allosteric links to the channel and the agonist binding site.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15615813     DOI: 10.1093/brain/awh364

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  13 in total

1.  A conserved Cys-loop receptor aspartate residue in the M3-M4 cytoplasmic loop is required for GABAA receptor assembly.

Authors:  Wen-yi Lo; Emmanuel J Botzolakis; Xin Tang; Robert L Macdonald
Journal:  J Biol Chem       Date:  2008-08-21       Impact factor: 5.157

Review 2.  An outline of desensitization in pentameric ligand-gated ion channel receptors.

Authors:  Angelo Keramidas; Joseph W Lynch
Journal:  Cell Mol Life Sci       Date:  2012-08-31       Impact factor: 9.261

3.  A novel fast-channel myasthenia caused by mutation in β subunit of AChR reveals subunit-specific contribution of the intracellular M1-M2 linker to channel gating.

Authors:  Xin-Ming Shen; Li Di; Shelley Shen; Yuying Zhao; Ann M Neumeyer; Duygu Selcen; Steven M Sine; Andrew G Engel
Journal:  Exp Neurol       Date:  2020-06-03       Impact factor: 5.330

4.  Escobar syndrome is a prenatal myasthenia caused by disruption of the acetylcholine receptor fetal gamma subunit.

Authors:  Katrin Hoffmann; Juliane S Muller; Sigmar Stricker; Andre Megarbane; Anna Rajab; Tom H Lindner; Monika Cohen; Eliane Chouery; Lynn Adaimy; Ismat Ghanem; Valerie Delague; Eugen Boltshauser; Beril Talim; Rita Horvath; Peter N Robinson; Hanns Lochmüller; Christoph Hübner; Stefan Mundlos
Journal:  Am J Hum Genet       Date:  2006-06-20       Impact factor: 11.025

5.  Investigation of Congenital Myasthenia Reveals Functional Asymmetry of Invariant Acetylcholine Receptor (AChR) Cys-loop Aspartates.

Authors:  Xin-Ming Shen; Joan Brengman; David Neubauer; Steven M Sine; Andrew G Engel
Journal:  J Biol Chem       Date:  2015-12-23       Impact factor: 5.157

Review 6.  Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment.

Authors:  Andrew G Engel; Xin-Ming Shen; Duygu Selcen; Steven M Sine
Journal:  Lancet Neurol       Date:  2015-04       Impact factor: 44.182

7.  Congenital myasthenic syndromes in Turkey: Clinical clues and prognosis with long term follow-up.

Authors:  Hacer Durmus; Xin-Ming Shen; Piraye Serdaroglu-Oflazer; Bulent Kara; Yesim Parman-Gulsen; Coskun Ozdemir; Joan Brengman; Feza Deymeer; Andrew G Engel
Journal:  Neuromuscul Disord       Date:  2017-11-28       Impact factor: 4.296

Review 8.  Further observations in congenital myasthenic syndromes.

Authors:  Andrew G Engel; Xin-Ming Shen; Duygu Selcen; Steven M Sine
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

Review 9.  What have we learned from the congenital myasthenic syndromes.

Authors:  Andrew G Engel; Xin-Ming Shen; Duygu Selcen; Steven M Sine
Journal:  J Mol Neurosci       Date:  2009-08-18       Impact factor: 3.444

10.  Mutations Causing Slow-Channel Myasthenia Reveal That a Valine Ring in the Channel Pore of Muscle AChR is Optimized for Stabilizing Channel Gating.

Authors:  Xin-Ming Shen; Tatsuya Okuno; Margherita Milone; Kenji Otsuka; Koji Takahashi; Hirofumi Komaki; Elizabeth Giles; Kinji Ohno; Andrew G Engel
Journal:  Hum Mutat       Date:  2016-08-21       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.